Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/IIa Study of SLIT Cisplatin by Inhalation in the Treatment of Patients Wtih Relapsed/Progressive Osteosarcoma Metastatic to the Lung

NCT00102531 is registered in ClinicalTrials.gov with Insmed Incorporated as lead sponsor.

NCT NCT00102531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00102531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/IIa Study of SLIT Cisplatin by Inhalation in the Treatment of Patients Wtih Relapsed/Progressive Osteosarcoma Metastatic to the Lung
Lead sponsor
Insmed Incorporated
Phase
Phase 1/2
Overall status
Completed
Start date
January 12, 2005
Completion date
March 17, 2008
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma metastatic